Modification of feeding behavior

Details Modification of feeding behavior Modification of feeding behavior

2002-09-24

2008-12-02

Weber, Jon P (Department: 1652)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C530S303000, C530S324000

Reexamination Certificate

active

07459432

ABSTRACT:
Methods are disclosed for decreasing calorie intake, food intake, and appetite in a subject. The methods include peripherally administering a therapeutically effective amount of PYY or an agonist thereof to the subject, thereby decreasing the calorie intake of the subject.

REFERENCES:
patent: 3773919 (1973-11-01), Boswell et al.
patent: 4002531 (1977-01-01), Royer
patent: 4175122 (1979-11-01), Lazarus
patent: 4179337 (1979-12-01), Davis et al.
patent: 4223017 (1980-09-01), Lazarus
patent: 4355025 (1982-10-01), Lazarus
patent: 4485045 (1984-11-01), Regen
patent: 4544545 (1985-10-01), Ryan et al.
patent: 4701441 (1987-10-01), Kalra
patent: 4829076 (1989-05-01), Szilagyi et al.
patent: 5026685 (1991-06-01), Boublik et al.
patent: 5122614 (1992-06-01), Zalipsky
patent: 5284839 (1994-02-01), Siren et al.
patent: 5349052 (1994-09-01), Delgado et al.
patent: 5428128 (1995-06-01), Mensi-Fattohi et al.
patent: 5574010 (1996-11-01), McFadden
patent: 5604203 (1997-02-01), Balasubramaniam
patent: 5635503 (1997-06-01), Poindexter et al.
patent: 5643575 (1997-07-01), Martinez et al.
patent: 5696093 (1997-12-01), Tseng et al.
patent: 5700486 (1997-12-01), Canal et al.
patent: 5728396 (1998-03-01), Peery et al.
patent: 5880131 (1999-03-01), Greenwald et al.
patent: 5889016 (1999-03-01), Bruce et al.
patent: 5912227 (1999-06-01), Croom et al.
patent: 5919901 (1999-07-01), Hu et al.
patent: 5936092 (1999-08-01), Shen et al.
patent: 5939380 (1999-08-01), Wang
patent: 5965392 (1999-10-01), Hu et al.
patent: 5989920 (1999-11-01), Gerald et al.
patent: 5993414 (1999-11-01), Haller
patent: 6001836 (1999-12-01), Poindexter et al.
patent: 6001970 (1999-12-01), Cascieri et al.
patent: 6046167 (2000-04-01), Balasurbramaniam
patent: 6048900 (2000-04-01), Connell et al.
patent: 6093692 (2000-07-01), Shen et al.
patent: 6127355 (2000-10-01), Greenwald et al.
patent: 6140354 (2000-10-01), Dax et al.
patent: 6191102 (2001-02-01), Dimarchi et al.
patent: 6201025 (2001-03-01), Dax et al.
patent: 6218408 (2001-04-01), Marzabadi et al.
patent: 6225330 (2001-05-01), Marzabadi et al.
patent: 6225445 (2001-05-01), Shen et al.
patent: 6316203 (2001-11-01), Gerald et al.
patent: 6340683 (2002-01-01), Marzabadi et al.
patent: 6348472 (2002-02-01), Poindexter et al.
patent: 6355478 (2002-03-01), Baez et al.
patent: 6372743 (2002-04-01), Darrow et al.
patent: 6380224 (2002-04-01), Dax et al.
patent: 6391877 (2002-05-01), Islam et al.
patent: 6391881 (2002-05-01), Sit
patent: 6399631 (2002-06-01), Elliot et al.
patent: 6407120 (2002-06-01), Carpino et al.
patent: 6410707 (2002-06-01), Wagner et al.
patent: 6410792 (2002-06-01), Connell et al.
patent: 6420532 (2002-07-01), Gerald et al.
patent: 6432960 (2002-08-01), Sit et al.
patent: 6436091 (2002-08-01), Harper et al.
patent: 6444675 (2002-09-01), Sit
patent: 6447743 (2002-09-01), Devic et al.
patent: 6447753 (2002-09-01), Edwards et al.
patent: 6620910 (2003-09-01), Calas et al.
patent: 2002/0141985 (2002-10-01), Pittner et al.
patent: 32 18 121 (1983-11-01), None
patent: 0 036 676 (1981-09-01), None
patent: 0 052 322 (1982-05-01), None
patent: 0 058 481 (1982-08-01), None
patent: 0 088 046 (1983-09-01), None
patent: 0 102 324 (1984-03-01), None
patent: 0 133 988 (1985-03-01), None
patent: 0 142 641 (1985-05-01), None
patent: 0 143 949 (1985-06-01), None
patent: 0 267 050 (1988-05-01), None
patent: 0 401 384 (1990-12-01), None
patent: 60-007934 (1985-01-01), None
patent: WO 80/01882 (1980-09-01), None
patent: WO 93/09227 (1993-05-01), None
patent: WO 93/19175 (1993-09-01), None
patent: WO 94/22467 (1994-10-01), None
patent: WO 95/06058 (1995-03-01), None
patent: WO 96/22783 (1996-08-01), None
patent: WO 97/37998 (1997-10-01), None
patent: WO 97/46579 (1997-12-01), None
patent: WO 98/20885 (1998-05-01), None
patent: WO 00/47219 (2000-08-01), None
patent: WO 00/59887 (2000-10-01), None
patent: WO 00/68197 (2000-11-01), None
patent: WO 00/78333 (2000-12-01), None
patent: WO 01/04156 (2001-01-01), None
patent: WO 01/14368 (2001-03-01), None
patent: WO 01/14386 (2001-03-01), None
patent: WO 01/35988 (2001-05-01), None
patent: WO 01/51078 (2001-07-01), None
patent: WO 01/66135 (2001-09-01), None
patent: WO 01/68699 (2001-09-01), None
patent: WO 01/76631 (2001-10-01), None
patent: WO 01/89554 (2001-11-01), None
patent: WO 02/03978 (2002-01-01), None
patent: WO 02/47712 (2002-06-01), None
patent: WO 02/066479 (2002-08-01), None
patent: WO 02/067918 (2002-09-01), None
Okada et al., “Peripherally not centrally administered peptide YY (PYY) decreased high fat diet intake,” Endocrinology, Abstract 520B, Jun. 9, 1993.
ExPASy Proteomics Tools, Compute pl/MW, http://ca.expasy.org/cgi-bin/pi—tool, printed on Apr. 10, 2007.
U.S. Appl. No. 60/324,406, filed Sep. 24, 2001, Cowley, et al.
Adrian et al., “Human distribution and release of a putative new gut hormone, pepide yy”Gastroenterology 89,1070-1077, (1985).
Allen, et al., “Radioimmunoassay of neuropeptide y”Regulatory Peptides 8:61-70 (1984).
Balasubramaniam et al., “Syntheses and receptor affinities of partial sequences of peptide yy (pyy)”Pept Res1(1):32-5, (1998).
Barrachina et al., “Leptin-induced decrease in food intake is not associated with changes in gastric emptying in lean mice”Am. J. Physiol.272, R1007-11, (1997).
Beck-Sickinger and Jung, “Structure-activity relationships of neuropeptide y analogues with respect to Y1and Y2receptors” Biopolymers 37:123-142, 1995.
Berglund, MM, Binding Properties of Three Neuropeptide Y Receptor Subtypes from Zebrafish: Comparison with Mammalian Y1 ReceptorsBiochem Pharmacol60(12):1815-22, (2000).
Broberger et al., “Subtypes Y1 and Y2 of the neuropeptide Y receptor are respectively expressed in pro-opiomelanocortin- and neuropeptide-Y-containing neurons of the rat hypothalamic arcuate nucleus”Neuroendocrinology 66,393-408, 1997.
Buchwald et al., “Long-term, continuous intracenous heparin administration by an implantable infusion pump in ambulatory patients with recurrent venous thrombosis”Surgery 88:507, 1980.
Butler et al., “Melanocortin-4 receptor is required for acute homeostatic responses to increased dietary fat”Nature Neuroscience 4,605-611, 2001.
Cabrele et al., “Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family”J Pept Sci 6(3):97-122, Mar. 2000.
Cowley, et al., “Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus”Nature,411, 480-484 (2001).
Doods, H.N., “Pharmacological characterization of the selective nonpeptide neuropeptide Y Y1 receptor antagonist BIBP 3226”J Pharmacol Exp Ther275(1):136-42, Oct. 1995.
Dumont et al., “Characterization of a selective neuropeptide Y/peptide YY Y2 receptor radioligand”Society for Neuroscience Abstracts19:726, 1993.
Eberlein et al., “A new molecular form of PYY: structural characterization of human PYY(3-36) and PYY(1-36)”Peptides10:797-803, 1989.
Edwards et al., “Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers”Am. J. Physiol. Endocrinol. Metab.281, E155-E166, 2001.
Epstein et al., “Biological activity of liposome-encapsulated murine interferon gamma is mediated by a cell membrance receptor”Proc. Natl. Acad. Sci. U.S.A.82:3688-3692, 1985.
Fournier et al., “Conformational and biological studies of neuropeptide Y analogs containing structural alterations”Mol Pharmacol45(1):93-101, Jan. 1994.
Gehlert et al., “Multiple receptors for the pancreatic polypeptide (pP-fold) family: Physiological implications”Proc Soc Exp Biol Med218:7-22, 1998.
Grandt et al., “Characterization of two forms of peptide YY, PYY(1-36) and PYY(3-36), in the rabbit”Regul. Pept.51,151-159, 1994.
Grandt et al., “Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36”Regulatory Peptid

Affiliated with

Also associated with

Rating

Modification of feeding behavior does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modification of feeding behavior, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modification of feeding behavior will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4024726